The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
American Association for the Treatment of Opioid Dependence, Inc.
225 Varick Street
New York, NY 10014
The American Association for the Treatment of Opioid Dependence, Inc., (AATOD) was founded in 1984 to promote the growth and development of opioid treatment services. The association currently represents 20 states and the District of Columbia, providing treatment to individuals in approximately 700 programs. Committed to enhancing the quality of patient care, the American Association for the Treatment of Opioid Dependence, in conjunction with the American Society of Addiction Medicine, developed clinical guidelines to assist individual practitioners and policy makers in the development of effective opioid treatment services. In addition, the association focuses on federal, state, and program specific treatment policies; advocates on behalf of affected individuals and their families; engages in professional and public education; and promotes the coordination of and communication among opioid treatment programs. The association also convenes a national conference every 18 months for researchers, treatment personnel, and policy makers. The association also provides a variety of materials including fact sheets and brochures, and maintains a web site with information about opioid treatment for patients and practitioners, national advisories and policy statements, news from the states, and conference/symposium registration materials.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.